The World Health Organization released the second edition of Risk reduction of cognitive decline and dementia on 15 July 2026, its first rewrite of the guidance since 2019. Two areas are new. WHO now says that reducing exposure to ambient air pollution, particularly fine particulate matter (PM2.5), and reducing exposure to household air pollution may reduce the risk or incidence of cognitive decline and dementia; both recommendations are graded conditional, with the certainty of evidence rated very low. It also issues a new recommendation that tailored multidomain interventions, meaning programmes customised to an individual's or a population's own risk factors, may be offered specifically to reduce risk; that recommendation is also conditional, but the certainty of evidence is rated moderate to high. WHO adds a general clinical remark that risk factors should be addressed holistically, because they often coexist and accumulate over the life course.

The guideline also updates existing recommendations on diet and nutrition, cognitive activity, social activity, and the management of hearing loss, obesity, hypertension and diabetes, and reaffirms others carried over from 2019, including physical activity, tobacco cessation and reduction of harmful alcohol use. Less widely reported is where WHO stopped. For the specific purpose of reducing dementia risk, the guideline development group found the evidence insufficient to recommend particular interventions for sleep-wake disorders, for pharmacological prevention of recurrent stroke, for interventions after traumatic brain injury, for vision impairment, or to prefer one antiretroviral therapy combination over another in the management of HIV. Sleep, stroke, head injury, vision and HIV were assessed for the first time; being assessed and being recommended are not the same thing.

The context WHO gives is that more than 57 million people worldwide live with dementia, that nearly 10 million people are newly diagnosed each year, that Alzheimer's disease accounts for an estimated 60 to 70 per cent of cases, and that up to 45 per cent of dementia risk is attributable to modifiable factors. That 45 per cent figure comes from population modelling of what might in theory be prevented or delayed if exposure to those factors were removed across whole populations; it is not a probability that applies to any one person, and WHO frames the guideline as advice for countries, health systems and clinicians rather than a personal prescription.

The counterpoint sits inside the document itself. A conditional recommendation, in the GRADE system WHO uses, signals that the balance of benefits and harms is uncertain or that the underlying evidence is weak; the air pollution recommendations rest largely on observational studies, which can show association but not cause. WHO also states that some interventions should not be used for dementia risk reduction alone, including routine vitamin B, vitamin E, omega-3 or multivitamin supplementation in people without a diagnosed deficiency, and menopausal hormone therapy for that purpose in older postmenopausal women. The Alzheimer's Association, which presented the guideline at its London conference on the day of release, said it is developing a United States clinical practice guideline on risk reduction expected in 2027.